537 |
Randomized Comparison of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Diabetic Patients |
Seong-Wook Park |
Jun. 05. 08 |
536 |
Impact of Diabetes on Long-Term Outcomes of Drug-Eluting Stents in Asian Patients |
Seung-Jung Park |
Jun. 05. 08 |
535 |
Safety of DES in Diabetics |
David E. Kandzari |
Jun. 05. 08 |
534 |
Why Should Diabetics Be Treated Differently? Different Drug MoA |
Keith D. Dawkins |
Jun. 05. 08 |
533 |
Comparative Trials of DES Safety and Efficacy Role of DES in Chronic Total Occlusions: Results of The ACROSS Trial Evaluating SES in Chronic Total Occlusions |
David E. Kandzari |
Jun. 05. 08 |
532 |
Durable Clinical Benefit Following Paclitaxel-Eluting Stent Deployment in Patients with Very Long Coronary Lesions: Multicenter Registry in Asia |
Sunao Nakamura |
Jun. 05. 08 |
531 |
Ostial Lesions Treated with the Szabo Technique |
Eulogio Garcia |
Jun. 05. 08 |
530 |
Optimal Stent Deployment of DES |
Augusto D. Pichard |
Jun. 05. 08 |
529 |
Late Stent Thrombosis Following Elective DES Implantation in Unprotected LMCA: A Multicenter Registry |
Alaide Chieffo |
Jun. 05. 08 |
528 |
Main-Compare Registry: What We've Learned |
Ki-Bae Seung |
Jun. 05. 08 |